Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Matthew Ho Zhi Guang"'
Autor:
Martin E. M. Parsons, Damien McParland, Paulina B. Szklanna, Matthew Ho Zhi Guang, Karen O’Connell, Hugh D. O’Connor, Christopher McGuigan, Fionnuala Ní Áinle, Amanda McCann, Patricia B. Maguire
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 4 (2017)
Nanoparticle tracking analysis (NTA) can be used to quantitate extracellular vesicles (EVs) in biological samples and is widely considered a useful diagnostic tool to detect disease. However, accurately profiling EVs can be challenging due to their s
Externí odkaz:
https://doaj.org/article/e26315b5ff804424971c1e028473ede8
Autor:
Dai-Bo Zhang, Yong-Li Zhang, Sheng-Hua Wu, Jing-Yuan Lu, Yu-Han Chen, Xiang-Hui Min, Kejie Zhang, Matthew Ho Zhi Guang, Qin Yao, Yan Chen, Hui-Qin Zhuo, Ai-Qi Gu
Publikováno v:
Acta Haematologica. 137:106-112
Mantle cell lymphoma (MCL) remains incurable and new treatments are needed, especially in the relapsed/refractory setting. We therefore investigated the effects of carfilzomib, a novel, long-acting, second-generation proteasome inhibitor, in MCL cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f393b4981969e3f10f3241b37994d868
https://doi.org/10.1159/000455939
https://doi.org/10.1159/000455939
Publikováno v:
Atlas of Genetics and Cytogenetics in Oncology and Haematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0277a962f70d1d4b13f3323947093db4
https://doi.org/10.4267/2042/69762
https://doi.org/10.4267/2042/69762
Autor:
Luke Paul Dunne, Peter O'Gorman, Giada Bianchi, Paul Dowling, Cathal Hanley, Li Zhang, Kenneth C. Anderson, Sinéad Lindsay, Despina Bazou, Matthew Ho Zhi Guang, Chia Yin Goh, Amanda McCann, Emma L Kavanagh
Publikováno v:
Cancers
Cancers, Vol 11, Iss 1, p 66 (2019)
Cancers, Vol 11, Iss 1, p 66 (2019)
Despite significant advances in cancer diagnostics and therapeutics the majority of cancer unfortunately remains incurable, which has led to continued research to better understand its exceptionally diverse biology. As a result of genomic instability
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f13c7dde6475edffad7e552ed0e5d9ba
https://pubmed.ncbi.nlm.nih.gov/30634515
https://pubmed.ncbi.nlm.nih.gov/30634515
Publikováno v:
Atlas of Genetics and Cytogenetics in Oncology and Haematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e7937364057282023f9fad6448b483f
https://doi.org/10.4267/2042/69019
https://doi.org/10.4267/2042/69019
Publikováno v:
Atlas of Genetics and Cytogenetics in Oncology and Haematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f96116a12f1bf8ac9fc9df15a2a0777
https://doi.org/10.4267/2042/69009
https://doi.org/10.4267/2042/69009
Autor:
Kenneth C. Anderson, Amanda McCann, Matthew Ho Zhi Guang, Paul Dowling, Despina Bazou, Peter O'Gorman, Li Zhang, Giada Bianchi
Publikováno v:
Leukemialymphoma. 59(3)
Multiple myeloma (MM) is among the most compelling examples of cancer in which research has markedly improved the length and quality of lives of those afflicted. Research efforts have led to 18 newly approved treatments over the last 12 years, includ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f77418f17c307bc44c00c56cdf0681de
https://pubmed.ncbi.nlm.nih.gov/28610537
https://pubmed.ncbi.nlm.nih.gov/28610537
Autor:
Yong-Li, Zhang, Matthew Ho Zhi, Guang, Hui-Qin, Zhuo, Xiang-Hui, Min, Qin, Yao, Ai-Qi, Gu, Sheng-Hua, Wu, Dai-Bo, Zhang, Jing-Yuan, Lu, Yan, Chen, Yu-Han, Chen, Ke-Jie, Zhang
Publikováno v:
Acta haematologica. 137(2)
Mantle cell lymphoma (MCL) remains incurable and new treatments are needed, especially in the relapsed/refractory setting. We therefore investigated the effects of carfilzomib, a novel, long-acting, second-generation proteasome inhibitor, in MCL cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::67b2000b18a97447bf2a4d6c58c42df7
https://pubmed.ncbi.nlm.nih.gov/28208145
https://pubmed.ncbi.nlm.nih.gov/28208145
Autor:
E. Collins, Emma L Kavanagh, Matthew Ho Zhi Guang, Melinda Halasz, Paul Dowling, Luke Gubbins, Peter O'Gorman, Michael Henry, Karolina Weiner-Gorzel, Aloysius McGoldrick, Amanda McCann, Patricia Fitzpatrick, M. Higgins, Sinéad Lindsay
Publikováno v:
Cancer Research. 78:457-457
Triple negative breast cancer (TNBC) is an aggressive subtype with relatively poor clinical outcomes and limited treatment options. Chemotherapy, while killing cancer cells, can result in the generation of highly chemoresistant therapeutic induced se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3ef48094ef6b3c84fbf60cf757c86ca
https://doi.org/10.1158/1538-7445.am2018-457
https://doi.org/10.1158/1538-7445.am2018-457